Last edition
News about "iPSC cell therapy"
Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies
Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.
IPSC Cell Therapy | 08/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy